Cited by 13HIV/AIDS drug development and treatmentHIV Research and TreatmentT-cell and Retrovirus Studies

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Intrinsic DNA synthesis fidelity of xenotropic murine leukemia virus-related virus reverse transcriptase

Open access
Barrioluengo, Verónica, Wang, Yi, Le Grice, Stuart F. J., Menéndez‐Arias, Luis·2012·The FEBS Journal

Abstract

Although recent reports have provided strong evidence to suggest that xenotropic murine leukemia virus‐related virus (XMRV) is unlikely to be the causative agent of prostate cancer and chronic fatigue syndrome, this recombinant retrovirus can nonetheless infect human cells in vitro and induce a chronic infection in macaques. In the present study, we determined the accuracy of DNA synthesis of the reverse transcriptases (RTs) of XMRV and Moloney murine leukemia virus (MoMLV) using a combination of pre‐steady‐state kinetics of nucleotide incorporation and an M13mp2‐based forward mutation assay. The results obtained were compared with those previously reported for the HIV type 1 BH10 strain (HIV‐1 BH10) RT. MoMLV and XMRV RTs were 13.9 and 110 times less efficient [as determined by the catalytic rate constant of the nucleotide incorporation reaction (kpol)/equilibrium constant (Kd)] than the HIV‐1 BH10 RT in incorporating correct nucleotides. Misinsertion and mispair extension kinetic studies demonstrated that MoMLV RT was more accurate than the HIV‐1 BH10 RT. In comparison with the MoMLV RT, the XMRV RT showed decreased mispair extension fidelity and was less faithful when misincorporating C or A opposite A. However, the XMRV RT showed stronger selectivity against G in misinsertion fidelity assays. Forward mutation assays revealed that XMRV and MoMLV RTs had similar accuracy of DNA‐dependent DNA synthesis, but were > 13 times more faithful than the HIV‐1 BH10 enzyme. The mutational spectra of XMRV and MoMLV RTs were similar in having a relatively higher proportion of frameshifts and transversions compared with the HIV‐1 BH10 RT. However, the XMRV polymerase was less prone to introduce large deletions and one‐nucleotide insertions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1742-4658.2012.08532.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In cell-free assays of DNA-dependent DNA synthesis, AMV and MLV RTs introduce nearly 10-fold fewer mutations than HIV-1 RT.

    “Based on cell-free assays designed to read mutations during DNA-dependent DNA synthesis, it has been shown that AMV and MLV RTs introduce nearly 10-fold fewer mutations when compared to HIV-1 RT (Roberts et al. 1988, 1989, Barrioluengo et al. 2012).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 39

  1. 10.1126/science.1179052 · DOI · Paper page
  2. 10.1002/rmv.673 · DOI
  3. 10.1016/j.tim.2011.08.005 · DOI
  4. 10.1186/1742-4690-7-108 · DOI
  5. 10.1186/1742-4690-7-109 · DOI
  6. 10.1186/1742-4690-7-111 · DOI
  7. 10.1186/1742-4690-8-13 · DOI
  8. 10.1126/science.1204963 · DOI
  9. 10.1128/JVI.00546-09 · DOI
  10. 10.1126/science.1213841 · DOI
  11. 10.1371/journal.pone.0015632 · DOI
  12. 10.1186/1743-422X-8-443 · DOI
  13. 10.1128/JVI.02411-10 · DOI
  14. 10.1016/j.virusres.2008.01.001 · DOI
  15. 10.1007/s00018-010-0346-2 · DOI
  16. 10.1093/nar/gkr694 · DOI
  17. 10.1016/j.jmb.2007.11.021 · DOI
  18. 10.1016/0076-6879(95)62020-6 · DOI
  19. 10.1042/BJ20101852 · DOI
  20. 10.2144/01305rr06 · DOI
  21. 10.1074/jbc.M412859200 · DOI
  22. 10.1016/j.jmb.2009.07.081 · DOI
  23. 10.1002/j.1460-2075.1990.tb08278.x · DOI
  24. 10.1021/bi00154a010 · DOI
  25. 10.1016/0014-5793(93)80067-5 · DOI
  26. 10.1128/MCB.9.2.469 · DOI · Paper page
  27. 10.3390/v1031137 · DOI
  28. 10.1016/S0021-9258(19)84799-3 · DOI
  29. 10.1128/JVI.72.5.4224-4230.1998 · DOI
  30. 10.1093/nar/26.12.3066 · DOI
  31. 10.1128/JVI.66.6.3683-3689.1992 · DOI
  32. 10.1016/S0021-9258(18)35818-6 · DOI
  33. 10.1016/j.pep.2010.12.003 · DOI
  34. 10.1006/abio.2001.5045 · DOI
  35. 10.1016/j.jmb.2005.04.004 · DOI
  36. 10.1016/S0021-9258(18)35706-5 · DOI
  37. 10.1021/bi981830g · DOI
  38. 10.1128/AAC.00716-10 · DOI
  39. 10.1002/prot.21711 · DOI

Cited by

Sorted by citations

Metadata

Authors
Barrioluengo, V., Wang, Y., Le Grice, S. F. J., & Menéndez‐Arias, L.
Affiliations
  • Consejo Superior de Investigaciones Científicas (ES)
  • National Cancer Institute (US)
Venue
The FEBS Journal
Publisher
Wiley
Published
2012-03-16
Volume
279
Issue
8
Pages
1433-1444
ISSN
  • 1742-464X (ISSN-L)
  • 1742-4658
OpenAlex
W1562708112
Cited by
13
References
3
Citations by year
2025: 2 · 2024: 1 · 2020: 1 · 2018: 2 · 2017: 1 · 2016: 1 · 2015: 1 · 2014: 1 · 2013: 3
FWCI
1.11
Type
journal article
Language
en
Open access
Locations
  • FEBS Journal (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
Funders
  • Styrelsen för Internationellt Utvecklingssamarbete
  • National Institutes of Health
  • National Cancer Institute (ZIABC010494)
Topics
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
Keywords
XMRV, reverse transcriptase, DNA synthesis fidelity, Moloney murine leukemia virus, HIV-1 reverse transcriptase, forward mutation assay, mutational spectra, frameshift mutation
MeSH terms
Amino Acid Sequence, Animals, Base Sequence, DNA Replication, DNA, Viral, Humans, Molecular Sequence Data, Moloney murine leukemia virus, Mutation, RNA-Directed DNA Polymerase, HIV-1, Bacteriophage M13, Sequence Homology, Amino Acid, Mice, Xenotropic murine leukemia virus-related virus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review